Skip to main content

Featured

Eddie Bauer Customers Face March 12 Deadline Amid Store Closures

                        Shoppers pass a closing sale at an Eddie Bauer store in Vaughan, Ont., on Wednesday, Feb. 4, 2026 Eddie Bauer shoppers are being urged to use their remaining gift cards and loyalty points before a fast‑approaching March 12 cutoff, as the retailer undergoes bankruptcy protection proceedings in both Canada and the United States. Court filings reveal that gift cards and Adventure Points rewards will no longer be accepted at closing store locations after this date, leaving customers with just under a month to redeem their balances.  The deadline comes as Catalyst Brands, the operator of Eddie Bauer’s North American stores, seeks a buyer while liquidating its retail footprint. Many locations are already offering steep discounts—some reaching 60%—as part of the wind‑down process. However, shoppers should note that all liquidation sales are final, with no returns permitted on discounted merchan...

article

New Cystic Fibrosis Drug Offers Hope, but Comes with a High Price

A new drug for cystic fibrosis, Trikafta, is providing significant hope for patients suffering from the genetic disorder. Trikafta has been shown to reduce hospital visits and improve overall lung function, offering patients a better quality of life. For those living with cystic fibrosis, which affects the respiratory and digestive systems, this advancement is nothing short of a breakthrough.

However, the cost of Trikafta is a major concern. Priced at around $300,000 per year, the drug is prohibitively expensive for many patients and their families. While some health programs and insurance plans may cover the cost, access to this life-changing medication remains a challenge.

As the debate over drug pricing and healthcare accessibility continues, the medical community and patient advocacy groups are calling for measures to ensure that Trikafta is available to all who need it, regardless of their financial situation.


Comments